Literature DB >> 12080957

Fabrazyme--recombinant protein treatment for Fabry's disease.

Debra Barngrover1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12080957

Source DB:  PubMed          Journal:  J Biotechnol        ISSN： 0168-1656            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.

Authors:  Denis G Ilyushin; Ivan V Smirnov; Alexey A Belogurov; Igor A Dyachenko; Tatiana Iu Zharmukhamedova; Tatjana I Novozhilova; Eugene A Bychikhin; Marina V Serebryakova; Oleg N Kharybin; Arkadii N Murashev; Konstantin A Anikienko; Eugene N Nikolaev; Natalia A Ponomarenko; Dmitry D Genkin; G Michael Blackburn; Patrick Masson; Alexander G Gabibov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

2.  α-Galactosidase A expressed in the salivary glands partially corrects organ biochemical deficits in the fabry mouse through endocrine trafficking.

Authors:  Michael J Passineau; Timothy Fahrenholz; Laurie Machen; Lee Zourelias; Katherine Nega; Rachel Paul; Mary J MacDougall; Olga Mamaeva; Richard Steet; Jarrod Barnes; H M Kingston; Raymond L Benza
Journal:  Hum Gene Ther       Date:  2011-01-27       Impact factor: 5.695

3.  Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

Authors:  T Heare; N J Alp; D A Priestman; A B Kulkarni; P Qasba; T D Butters; R A Dwek; K Clarke; K M Channon; F M Platt
Journal:  J Inherit Metab Dis       Date:  2006-12-25       Impact factor: 4.982

4.  Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.

Authors:  D G Ilyushin; O M Haertley; T V Bobik; O G Shamborant; E A Surina; V D Knorre; P Masson; I V Smirnov; A G Gabibov; N A Ponomarenko
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.